Biogen Switzerland

PES is delighted to be supporting Biogen on their new large-scale biotech facility in Solothurn, Switzerland.

Our team on site is focused on providing automation and validation support during the commissioning and qualification of the facility.

Biogen is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the treatment of neurodegenerative, hematologic, and autoimmune diseases to patients worldwide.